Detalhe da pesquisa
1.
Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.
N Engl J Med
; 384(6): 541-549, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567193
2.
New viral vectors for infectious diseases and cancer.
Semin Immunol
; 50: 101430, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262065
3.
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy.
Curr Opin Oncol
; 35(2): 94-99, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721894
4.
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer.
Int J Mol Sci
; 24(23)2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38068911
5.
Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance.
Int J Mol Sci
; 22(24)2021 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34948316
6.
Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing.
Int J Mol Sci
; 22(2)2021 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33418877
7.
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine.
Vaccines (Basel)
; 12(3)2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543959
8.
Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors.
Mol Ther Oncol
; 32(1): 200760, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38596303
9.
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine.
Cancer Immunol Res
; 12(4): 440-452, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331413
10.
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses.
Clin Cancer Res
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506710
11.
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.
J Transl Med
; 11: 62, 2013 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497415
12.
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity.
J Immunother Cancer
; 11(4)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37117006
13.
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer.
Front Immunol
; 14: 1156714, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180141
14.
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes.
Blood
; 115(7): 1374-84, 2010 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19903903
15.
Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection.
Sci Transl Med
; 14(657): eabo7604, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947675
16.
A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma.
Mol Ther
; 18(8): 1559-67, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20531395
17.
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion.
J Immunother Cancer
; 9(11)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824160
18.
VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens' Prediction.
Vaccines (Basel)
; 9(8)2021 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452005
19.
Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates.
Mol Ther
; 17(10): 1804-13, 2009 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19623161
20.
Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus.
Cancers (Basel)
; 12(11)2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213060